Cipla Technologies, Pulmatrix agree for development and commercialization of Pulmazole
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Subscribe To Our Newsletter & Stay Updated